Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22, as the market digested weaknesses from its fourth-quarter and full-year earnings report. | Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22 as the market digested weaknesses from its fourth-quarter and full-year earnings report.
START SELLING WITH BigBCC TODAY
Start your free trial with BigBCC today.
BLOG | Business
Abbott shares sag as global diagnostic, nutrition business sales declines drag on earnings





